Surgery for Primary Central Nervous System Lymphoma: Is It Time for Reevaluation?
A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials? - Jakobsen - Annals of Lymphoma
Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma | NEJM
Non-Hodgkin lymphoma - The Lancet
Medical Sciences | Free Full-Text | Epidemiology of Non-Hodgkin's Lymphoma
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley Online Library
Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram
Non-Hodgkin Lymphoma (NHL) | Treatment Challenges
prognosis of non Hodgkin's lymphoma - Primary Care Notebook
Median Survival Time - an overview | ScienceDirect Topics
Intercontinental Asian Study Compiles the Relative Incidence of
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram
Long‐term survivors of childhood, adolescent and young adult non‐Hodgkin lymphoma - Ehrhardt - 2019 - British Journal of Haematology - Wiley Online Library
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
